+Compare
OSUR
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
535.7M

OSUR OraSure Technologies Forecast, Technical & Fundamental Analysis

a manufacturer of oral fluid specimen collection devices

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for OSUR with price predictions
07:00 PM EST Dec 07, 2023

OSUR's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for OSUR moved out of overbought territory on December 06, 2023. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 instances where the indicator moved out of the overbought zone. In of the 28 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 06, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on OSUR as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OSUR turned negative on December 04, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSUR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

OSUR moved above its 50-day moving average on November 07, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for OSUR crossed bullishly above the 50-day moving average on November 13, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for OSUR moved above the 200-day moving average on November 24, 2023. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OSUR advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

OSUR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 196 cases where OSUR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OSUR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.319) is normal, around the industry mean (25.240). P/E Ratio (11.186) is within average values for comparable stocks, (79.553). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.249). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (1.186) is also within normal values, averaging (44.190).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OSUR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NASDAQ:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NASDAQ:MDT), Boston Scientific Corp (NASDAQ:BSX), Edwards Lifesciences Corp (NASDAQ:EW), IQVIA Holdings (NASDAQ:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.41B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -0%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was -10%. SERA experienced the highest price growth at 118%, while IMMVF experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -15%. For the same stocks of the Industry, the average monthly volume growth was -48% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 60
SMR Rating: 84
Profit Risk Rating: 87
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

OSUR is expected to report earnings to fall 66.07% to 9 cents per share on February 07

OraSure Technologies OSUR Stock Earnings Reports
Q4'23
Est.
$0.09
Q3'23
Beat
by $0.21
Q2'23
Beat
by $0.16
Q1'23
Beat
by $0.31
Q4'22
Beat
by $0.35
The last earnings report on November 07 showed earnings per share of 27 cents, beating the estimate of 5 cents. With 480.80K shares outstanding, the current market capitalization sits at 535.70M.
A.I. Advisor
published General Information

General Information

a manufacturer of oral fluid specimen collection devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
220 East First Street
Phone
+1 610 882-1820
Employees
840
Web
https://www.orasure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYVCX182.792.59
+1.44%
Rydex Energy Services C
IHSAX16.750.14
+0.84%
Hartford Small Company A
NSCFX51.500.38
+0.74%
Nuveen Small-Cap Value Opps R6
DUSQX26.340.12
+0.46%
DFA US Large Cap Equity Institutional
AEYIX8.71-0.01
-0.11%
American Century Equity Income C

OSUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, OSUR has been loosely correlated with RVTY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OSUR jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSUR
1D Price
Change %
OSUR100%
+3.05%
RVTY - OSUR
42%
Loosely correlated
-0.72%
NTRA - OSUR
38%
Loosely correlated
+0.36%
IRTC - OSUR
36%
Loosely correlated
+2.64%
OPK - OSUR
34%
Loosely correlated
+1.87%
TWST - OSUR
31%
Poorly correlated
+2.16%
More

Groups containing OSUR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSUR
1D Price
Change %
OSUR100%
+3.05%
medical research
(undefined stocks)
33%
Loosely correlated
+0.01%
diagnostics
(undefined stocks)
33%
Poorly correlated
+0.28%
medical service
(undefined stocks)
33%
Poorly correlated
+0.17%
Medical Specialties
(undefined stocks)
31%
Poorly correlated
+0.20%
Medical Specialties
(undefined stocks)
31%
Poorly correlated
+0.20%
More